Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease.

Dane, Kathryn E; Lindsley, John P; Kickler, Thomas; Streiff, Michael B; Moliterno, Alison; Yui, Jennifer; Naik, Rakhi; Chaturvedi, Shruti

Dane, Kathryn E; Lindsley, John P; Kickler, Thomas; Streiff, Michael B; Moliterno, Alison; Yui, Jennifer; Naik, Rakhi; Chaturvedi, Shruti.

Afiliação

Dane KE; Department of Pharmacy and.
Lindsley JP; Department of Pharmacy and.
Kickler T; Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD.
Streiff MB; Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD.
Moliterno A; Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD.
Yui J; Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD.
Naik R; Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD.
Chaturvedi S; Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD.

Blood Adv ; 5(14): 2813-2816, 2021 07 27.

Article em En | MEDLINE | ID: mdl-34269797

Assuntos

Doenças de von Willebrand; Fator de von Willebrand; Hemorragia/tratamento farmacológico; Hemorragia/etiologia; Hemostasia; Humanos; Imunoglobulinas Intravenosas/uso terapêutico; Doenças de von Willebrand/tratamento farmacológico

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / Fator de von Willebrand Tipo de estudo: Etiology_studies / Guideline Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google